SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point Laboratories board approves un-audited financial results

05 Nov 2020 Evaluate

Caplin Point Laboratories has informed that the Board of Directors of the Company at their meeting held today (November 05, 2020) considered and approved the Un-audited Financial Results for the quarter/ half year ended September 30, 2020. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company enclosed Un-audited Financial Results (Consolidated and Standalone) for the quarter/ half year ended September 30, 2020; Limited Review Report (Consolidated and Standalone) for Un-audited Financial Results; Press Release on the above Un-audited Financial Results; and Investors Presentation.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1853.50 -3.85 (-0.21%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×